<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Neonatal acute kidney injury: Pathogenesis, etiology, clinical presentation, and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Neonatal acute kidney injury: Pathogenesis, etiology, clinical presentation, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Neonatal acute kidney injury: Pathogenesis, etiology, clinical presentation, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tej K Mattoo, MD, DCH, FRCP</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard Martin, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">F Bruder Stapleton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 14, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1201172246"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Acute kidney injury (AKI), formerly referred to as acute renal failure, is defined as an acute reduction in kidney function that results in a decline in glomerular filtration rate (GFR), leading to a decrease in urine output and retention of urea and other nitrogenous waste products. AKI is an important contributing factor to the morbidity and mortality of critically ill neonates.</p><p>The pathogenesis, etiology, presentation, and diagnosis of neonatal AKI are presented in this topic review. The diagnostic evaluation, management, and prognosis of neonatal AKI in children are presented separately. (See  <a class="medical medical_review" href="/z/d/html/111976.html" rel="external">"Neonatal acute kidney injury: Evaluation, management, and prognosis"</a>.)</p><p class="headingAnchor" id="H1520048979"><span class="h1">DEFINITION</span><span class="headingEndMark"> — </span>AKI is typically defined as a decrease in glomerular filtration rate (GFR), which is traditionally defined by an increase in serum creatinine (SCr).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>SCr-based definitions</strong> – For clinical care, neonatal AKI has been most commonly defined as:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>SCr ≥1.5 mg/dL (133 micromol/L), <strong>or</strong></p><p class="bulletIndent2"><span class="glyph">•</span>An increase in SCr of at least 0.2 to 0.3 mg/dL (17 to 27 micromol/L) per day from a previous lower value</p><p></p><p class="bulletIndent1">Of note, the SCr value at birth reflects the maternal SCr and normally decreases over time (see <a class="local">'Normal neonatal kidney function'</a> below). However, this definition underestimates the prevalence because, during early AKI, a reduction in GFR has a modest effect on creatine excretion and the level may remain unchanged.</p><p></p><p class="bulletIndent1">For preterm infants, SCr may also be underestimated due the effects of gestational age (GA) and postnatal age. Efforts have been made to reach a more accurate consensus definition based on normative data; however, it has been challenging to obtain this information, especially in very preterm (VPT) infants (GA &lt;32 weeks). For preterm infants, the diagnosis of AKI is based on exceeding critical SCr [<a href="#rid1">1,2</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>GA 24 to 27 weeks – &gt;1.6 mg/dL</p><p class="bulletIndent2"><span class="glyph">•</span>GA 28 to 29 weeks – &gt;1.1 mg/dL</p><p class="bulletIndent2"><span class="glyph">•</span>GA 30 to 32 weeks – &gt;1.0 mg/dL</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>SCr- and urine output-based definition</strong> – The Kidney Disease: Improving Global Outcomes (KDIGO) definition for AKI in newborns classifies the severity into stages based on changes in SCr and urine output [<a href="#rid3">3-5</a>]. This definition is used primarily for research purposes.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 0 – No significant change in SCr, or rise &lt;3 mg/dL (26.5 micromol/L) <strong>and</strong> urine output &gt;1 mL/kg/hour.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 1 – Increase in SCr by ≥0.3 mg/dL (≥26.5 micromol/L) within 48 hours <strong>or</strong> increase in SCr by 150 to &lt;200 percent from previous trough level within seven days, <strong>or</strong> urine output between 0.5 and 1 mL/kg/hour.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 2 – Increase in SCr by 200 to &lt;300 percent from previous trough level, <strong>or</strong> urine output between 0.3 and 0.5 mL/kg/hour.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 3 – Increase in SCr by &gt;300 percent, <strong>or</strong> SCr ≥2.5 mg/dL (221 micromol/L), <strong>or</strong> receipt of dialysis, <strong>or</strong> urine output &lt;0.3 mL/kg/hour.</p><p></p><p class="bulletIndent1">In a registry study of serial measures SCr values during the first week of life, the optimal thresholds to predict mortality area under curve and specificity were SCr ≥0.1 and ≥0.3 mg/dL for infants &gt;29 weeks GA and SCr ≥0.3 and ≥0.6 mg/dL for infants ≤29 weeks GA [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cystatin C-based definition</strong> – Cystatin C is a useful biomarker for neonatal kidney function because it does not cross the placenta, so neonatal concentrations are not affected by maternal kidney function. Cystatin C is relatively stable during the neonatal period in healthy neonates [<a href="#rid7">7</a>]. A study of more than 50,000 hospitalized neonates in China defined neonatal AKI as serum cystatin C ≥2.2 mg/L or an increase in cystatin C of ≥25 percent during the neonatal period [<a href="#rid8">8</a>]. This cystatin-C based definition was 6.5 times more sensitive in predicting in-hospital mortality compared with a definition based on SCr (≥0.3 mg/dL or ≥50 percent increase in concentrations).</p><p></p><p class="headingAnchor" id="H1"><span class="h1">NORMAL NEONATAL KIDNEY FUNCTION</span><span class="headingEndMark"> — </span>The neonate is more vulnerable to AKI compared with older individuals due to functional and developmental immaturity of the neonatal kidney that affects glomerular filtration and tubular function (eg, concentrating ability), hemodynamic changes that occur at delivery, and risk of hypovolemia due to large insensible water losses because of relatively larger body surface area to mass compared with older children and adults.</p><p class="headingAnchor" id="H1201172303"><span class="h2">Glomerular filtration rate</span><span class="headingEndMark"> — </span>It is challenging to ascertain normal neonatal glomerular filtration rate (GFR) due to variability based on gestational age (GA) and postnatal physiological changes and the difficulty of performing accurate clearance measurements [<a href="#rid9">9,10</a>]. Although measurement of inulin clearance is the gold standard to determine GFR, it is difficult to use as it requires an intravenous priming dose followed by continuous infusion (see  <a class="medical medical_review" href="/z/d/html/2359.html" rel="external">"Assessment of kidney function", section on 'Assessment of GFR'</a>). As a result, neonatal GFR values are based on creatinine clearance measurements.</p><p>The following are reference values from a prospective cohort study of preterm infants between 27 to 31 weeks of age compared with term infants [<a href="#rid9">9</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>At birth, GFR is lower with lower GA. Very preterm (VPT) infants (GA less than 32 weeks) had a reduced GFR because renal embryogenesis is not completed until 35 weeks gestation.</p><p></p><p class="bulletIndent1">Reported average GFR based on creatinine clearance measurements at birth or within the first three days of life varied by GA:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>27 weeks gestation – 13.4 mL/min per 1.73 m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>28 weeks gestation – 16.2 mL/min per 1.73 m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>29 weeks gestation – 19.1 mL/min per 1.73 m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>30 weeks gestation – 21.9 mL/min per 1.73 m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>31 weeks gestation – 24.9 mL/min per 1.73 m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>Term infants – 26 mL/min per 1.73 m<sup>2</sup></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>GFR increased postnatally in all infants with the following reported average GFR based on creatinine clearance measurements at two weeks of age by GA:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>27 weeks gestation – 16.2 mL/min per 1.73 m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>28 weeks gestation – 19.1 mL/min per 1.73 m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>29 weeks gestation – 21.9 mL/min per 1.73 m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>30 weeks gestation – 24.8 mL/min per 1.73 m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>31 weeks gestation – 27.6 mL/min per 1.73 m<sup>2</sup></p><p class="bulletIndent2"><span class="glyph">•</span>Term infants – 54 mL/min per 1.73 m<sup>2</sup></p><p></p><p class="headingAnchor" id="H1201172310"><span class="h2">Serum creatinine</span><span class="headingEndMark"> — </span>Clinically, serum creatinine (SCr) values are the most convenient method to estimate GFR. Similar to GFR, SCr normally varies with gestational and postnatal age. SCr at birth is equal to the concentration in the mother (approximately 1 mg/dL [88 micromol/L]). In term infants, SCr declines rapidly in the first or two weeks of life to nadir values (SCr 0.2 to 0.4 mg/dL [18 to 35 micromol/L]), which remain stable through the first year of life [<a href="#rid11">11-13</a>], whereas in preterm infants, the decline is slower and nadir values are reached over the first one to two months. In VPT infants (GA &lt;32 weeks), SCr may increase after birth, most likely due to low GFR and tubular reabsorption of creatinine, followed by a slower decline over two months [<a href="#rid11">11,13</a>]. SCr values for VPT infants and extremely preterm infants (GA &lt;28 weeks) over the first months of life are inversely related to decreasing GA [<a href="#rid13">13,14</a>]. As a result, SCr levels remain higher in extremely preterm infants and VPT infants compared with term infants in the first months of life  (<a class="graphic graphic_table graphicRef111831" href="/z/d/graphic/111831.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/2359.html" rel="external">"Assessment of kidney function"</a>.)</p><p class="headingAnchor" id="H1201172317"><span class="h2">Time of first void and urine volume</span><span class="headingEndMark"> — </span>Although the time of the first void is variable, at least 50 percent of newborns void by eight hours of age and nearly all before 24 hours [<a href="#rid15">15</a>]. Urine output is not affected by GA or postnatal age during the first week of life, averaging 3 to 4 mL/kg per hour [<a href="#rid10">10</a>]. Similar to older patients, neonatal AKI may be oliguric (urine volume less than 1 mL/kg per hour) or nonoliguric, depending on the severity of the reduction in GFR and the degree of tubular reabsorption.</p><p class="headingAnchor" id="H2707356920"><span class="h2">Tubular function</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urinary concentration</strong> – Urine-concentrating ability is limited in newborns compared with older individuals. The maximum urine concentration that can be achieved increases from 400 mosmol/kg in the first few days after birth to 1200 mosmol/kg at one year of age. The reasons for poor urine-concentrating ability in infants include low corticomedullary solute gradient, decreased formation of cyclic adenosine monophosphate in response to antidiuretic hormone, a short loop of Henle, and interference by prostaglandins [<a href="#rid16">16-18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sodium reabsorption</strong> – Similar to GFR, tubular reabsorption is lower in neonates compared with older individuals and is affected by GA and postnatal age. In particular, tubular function is immature in VPT infants (GA &lt;32 weeks), with decreasing sodium reabsorption as GA decreases [<a href="#rid10">10</a>]. As a result, the use of fractional excretion of sodium to differentiate between prerenal and intrinsic AKI has limited utility in VPT infants. In addition, the value used to differentiate between prerenal and intrinsic disease is higher in term or late preterm infants. (See  <a class="medical medical_review" href="/z/d/html/111976.html" rel="external">"Neonatal acute kidney injury: Evaluation, management, and prognosis", section on 'Fractional excretion of sodium'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bicarbonate reabsorption</strong> – Neonates have a lower threshold for proximal renal tubular bicarbonate reabsorption, resulting in smaller proportion of reabsorbed filtered bicarbonate than in older children and adults. As a result, infants have a lower normal serum/plasma bicarbonate compared with older children and adults (20 versus 24 mEq/L) [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acid excretion</strong> – The maximum net acid excretion by the distal nephron is limited in newborn infants, especially preterm infants [<a href="#rid20">20</a>].</p><p></p><p class="headingAnchor" id="H2"><span class="h1">INCIDENCE</span><span class="headingEndMark"> — </span>The reported incidence of neonatal AKI varies and is dependent on the definition of neonatal AKI used, the characteristics of the study population (eg, term versus preterm infants, severity of illness), and whether or not proactive surveillance of kidney function was performed (see <a class="local">'Definition'</a> above). The risk of AKI is higher in very preterm (VPT) infants and increases with the severity of illness. Previous studies most likely underestimated the incidence of AKI [<a href="#rid4">4</a>].</p><p>Observational studies from the United States report an incidence that ranges from 20 to 40 percent for infants cared for in neonatal intensive care units [<a href="#rid21">21-26</a>]. The incidence, including severe AKI, increases with lower gestational age (GA) and appears to be greater in extremely preterm infants (GA &lt;28 weeks) than in more mature infants [<a href="#rid27">27-29</a>]. In the Preterm Epo Neuroprotection trial, severe AKI occurred in 19 percent of the entire study cohort (168 of 900 infants) and stage 3 AKI occurred in 60 neonates (7 percent) and was associated with mortality [<a href="#rid28">28</a>].</p><p>Other high-risk neonatal groups include VPT infants with the following [<a href="#rid4">4</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Perinatal asphyxia</p><p class="bulletIndent1"><span class="glyph">●</span>Congenital diaphragmatic hernia</p><p class="bulletIndent1"><span class="glyph">●</span>Complex cardiac disease requiring cardiac surgery</p><p class="bulletIndent1"><span class="glyph">●</span>Treatment with extracorporal membrane oxygenation</p><p></p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS AND ETIOLOGY</span><span class="headingEndMark"> — </span>Determining the underlying pathogenesis and etiology is important to help guide management decisions (see  <a class="medical medical_review" href="/z/d/html/111976.html" rel="external">"Neonatal acute kidney injury: Evaluation, management, and prognosis", section on 'Directed therapy based on etiology'</a>). The causes of neonatal AKI can be divided into pathophysiologic categories based on the anatomical location of the initial injury  (<a class="graphic graphic_table graphicRef63913" href="/z/d/graphic/63913.html" rel="external">table 2</a>) [<a href="#rid30">30</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Prerenal AKI due to inadequate renal perfusion – 85 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Intrinsic AKI due to intrarenal pathology – 11 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Postrenal AKI due to obstruction to the flow of urine – 3 percent</p><p></p><p class="headingAnchor" id="H1904485514"><span class="h2">Prerenal disease</span><span class="headingEndMark"> — </span>Prerenal disease, also referred to as volume-responsive or functional AKI<em>,</em> is caused by reduced renal perfusion and is the most common form of neonatal AKI. It is typically due to hypovolemia or reduction of effective circulation.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypovolemia</strong> – Neonates are at increased risk for hypovolemia due to their increased insensible water loss, limited urine-concentrating ability, and concomitant conditions that result in excessive fluid loss such as:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bleeding</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Diarrhea</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increased evaporative fluid loss due to use of radiant warmers, some phototherapy devices, compromise of skin integrity (eg, abdominal wall defect), or thinness of the skin seen in extremely low birth weight infants (birth weight &lt;1000 g)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reduction of effective circulation</strong> – Neonatal conditions associated with reduced effective circulation include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Impaired cardiac output (eg, myocardial injury [perinatal asphyxia], critical congenital heart defects  (<a class="graphic graphic_table graphicRef103087" href="/z/d/graphic/103087.html" rel="external">table 3</a>), complete heart block)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sepsis</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Third spacing (movement of fluid from the vascular space into the interstitium) from acute intestinal injury (eg, necrotizing enterocolitis), hypoalbuminemia due to nephrotic syndrome or hepatic failure, and/or capillary leak (eg, perinatal asphyxia, and hydrops fetalis)</p><p></p><p class="headingAnchor" id="H2336871917"><span class="h3">Risk factors</span><span class="headingEndMark"> — </span>Neonates are more vulnerable to prerenal AKI compared with older patients because of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Urine-concentrating ability is limited in newborns compared with older children, which increases the risk of volume depletion if intake is reduced and/or fluid loss is increased. (See <a class="local">'Tubular function'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Insensible water loss through the skin is higher in newborns who have a greater body surface area for their mass compared with older children and adults. Insensible losses are increased by radiant warmers or some phototherapy devices.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>At birth, changes in fetal to postnatal circulation include a substantial increase in renal blood flow (RBF) as renal vascular resistance decreases and systemic blood pressure (BP) increases. As a proportion of cardiac output, RBF increases from 2 to 4 percent in the fetus to approximately 10 percent by one week after birth (normal adult value approximately 20 percent). Interference with this transition, as may occur with congenital heart disease or perinatal asphyxia, may lead to diminished kidney function.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Autoregulation of RBF, in which small changes in systemic BP produce parallel changes in afferent renal vascular resistance so that a constant RBF is maintained over a range of systemic BP, is set at a lower range of BP for infants compared with adults. This reduces a newborn's ability to compensate for significant hemodynamic changes and may lead to compromised kidney function. Impaired autoregulation predisposes to AKI when the BP is reduced [<a href="#rid31">31-33</a>].</p><p></p><p class="headingAnchor" id="H2018105675"><span class="h2">Intrinsic renal disease</span><span class="headingEndMark"> — </span>Intrinsic or intrarenal AKI is caused by a renal pathology that results in:</p><p class="bulletIndent1"><span class="glyph">●</span>Tubular and/or interstitial injury</p><p class="bulletIndent1"><span class="glyph">●</span>Renal vasculature disease</p><p class="bulletIndent1"><span class="glyph">●</span>Glomerular and cystic renal disease</p><p></p><p class="headingAnchor" id="H536934595"><span class="h3">Tubular and interstitial disease</span><span class="headingEndMark"> — </span>Acute tubular necrosis is the most common cause of intrinsic neonatal AKI. Tubular injury can be multifactorial and include the following mechanisms:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ischemic injury</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prolonged and/or severe renal hypoperfusion – Although hypoperfusion usually results in prerenal AKI, prolonged hypoperfusion causes direct tubular endothelial and epithelial cell injury from ischemia and inflammation [<a href="#rid34">34-37</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Perinatal asphyxia – Perinatal asphyxia can lead to hypoxia (lack of oxygen). Severe asphyxia results in diffuse tubular damage and dysfunction with impaired reabsorption of sodium and water and decreased glomerular filtration rate (GFR). For infants with milder asphyxia, there may be a loss of renal-concentrating ability. (See  <a class="medical medical_review" href="/z/d/html/4975.html" rel="external">"Perinatal asphyxia in term and late preterm infants", section on 'Acute kidney injury'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prenatal and postnatal nephrotoxic exposures</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Maternal drug use – Maternal use of drugs that may affect the RBF of the fetus and neonate include nonsteroidal inflammatory drugs (NSAIDs). NSAIDs inhibit cyclooxygenase enzymes, with subsequent reduction in prostaglandin synthesis leading to reduced neonatal peritubular blood flow, thereby increasing the risk of ischemic acute tubular necrosis [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/z/d/html/7998.html" rel="external">"Safety of rheumatic disease medication use during pregnancy and lactation", section on 'NSAIDs'</a> and  <a class="medical medical_review" href="/z/d/html/7230.html" rel="external">"NSAIDs: Acute kidney injury", section on 'Mechanism of acute kidney injury'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Postnatal nephrotoxic exposure – In the neonate, the most common nephrotoxic drugs resulting in renal tubular damage include aminoglycosides, prostaglandin synthesis inhibitors (eg, <a class="drug drug_pediatric" data-topicid="13380" href="/z/d/drug information/13380.html" rel="external">indomethacin</a>), amphotericin B, and <a class="drug drug_pediatric" data-topicid="12874" href="/z/d/drug information/12874.html" rel="external">vancomycin</a> [<a href="#rid4">4,38-40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sepsis</strong> – Although sepsis is often associated with prerenal AKI due to renal hypoperfusion, there is evidence that sepsis also results in direct tubular injury. (See  <a class="medical medical_review" href="/z/d/html/1597.html" rel="external">"Pathophysiology of sepsis", section on 'Kidney'</a> and  <a class="medical medical_review" href="/z/d/html/7228.html" rel="external">"Pathogenesis and etiology of ischemic acute tubular necrosis", section on 'Sepsis'</a>.)</p><p></p><p class="headingAnchor" id="H2839714002"><span class="h3">Renal vasculature disease</span><span class="headingEndMark"> — </span>In the neonate, bilateral renal vascular thrombosis can result in intrinsic renal failure. A more common manifestation of less severe renal vascular thrombosis is hypertension. (See  <a class="medical medical_review" href="/z/d/html/5001.html" rel="external">"Etiology, clinical features, and diagnosis of neonatal hypertension"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Renal artery thrombosis</strong> – Although thrombi are common in newborns with umbilical artery catheters and usually are asymptomatic [<a href="#rid41">41,42</a>], severe bilateral renal artery thrombosis can cause AKI [<a href="#rid43">43,44</a>]. Thrombi that form on the tip or surface of the catheter can partially or completely occlude the abdominal aorta, thereby decreasing renal perfusion. These thrombi may embolize to the renal artery, resulting in areas of infarction and increased renin release [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/z/d/html/5912.html" rel="external">"Neonatal thrombosis: Clinical features and diagnosis", section on 'Catheter-associated thrombosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Renal vein thrombosis (RVT)</strong> – RVT is uncommon, with an incidence estimated as 2.2 per 100,000 live births [<a href="#rid46">46</a>]. Approximately one-half of affected infants are preterm [<a href="#rid46">46</a>]. Bilateral RVT is generally associated with irreversible renal failure. RVT typically presents with a palpable flank mass, often accompanied by hypertension and reduced urine output if bilateral. Affected infants have gross or microscopic hematuria, proteinuria, and diminished kidney function if bilateral. (See  <a class="medical medical_review" href="/z/d/html/5912.html" rel="external">"Neonatal thrombosis: Clinical features and diagnosis", section on 'Renal vein thrombosis'</a>.)</p><p></p><p class="headingAnchor" id="H1289085458"><span class="h3">Glomerular and cystic renal disease</span><span class="headingEndMark"> — </span>Intrinsic AKI due to glomerular disease in the newborn is rare. More commonly, neonatal kidney dysfunction due to glomerular disorders is due to chronic kidney disease (CKD) caused by congenital anomalies of the kidney and urinary tract (CAKUT), genetic disorders (polycystic kidney), and congenital nephrotic syndrome, which can present in a similar manner as AKI. (See <a class="local">'Differential diagnosis'</a> below and  <a class="medical medical_review" href="/z/d/html/6110.html" rel="external">"Overview of congenital anomalies of the kidney and urinary tract (CAKUT)"</a> and  <a class="medical medical_review" href="/z/d/html/6138.html" rel="external">"Autosomal recessive polycystic kidney disease in children", section on 'Neonatal'</a> and  <a class="medical medical_review" href="/z/d/html/15319.html" rel="external">"Autosomal dominant polycystic kidney disease (ADPKD) in children"</a> and  <a class="medical medical_review" href="/z/d/html/6137.html" rel="external">"Congenital nephrotic syndrome"</a>.)</p><p class="headingAnchor" id="H1688022318"><span class="h2">Postrenal disease</span><span class="headingEndMark"> — </span>Postrenal or obstructive AKI is due to obstruction of urinary flow from both kidneys or obstruction of the upper urinary tract of a solitary kidney. Therefore, postrenal neonatal AKI is usually due to anatomic bladder obstruction (eg, posterior urethral valves) or bilateral anomalies of the renal pelvis or ureter. (See  <a class="medical medical_review" href="/z/d/html/6575.html" rel="external">"Clinical presentation and diagnosis of posterior urethral valves"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">CLINICAL PRESENTATION</span><span class="headingEndMark"> — </span>Neonatal AKI can present in one of the following clinical settings:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Kidney function monitoring of at-risk asymptomatic patients</strong> – Monitoring serum creatinine (SCr) in at-risk asymptomatic infants identifies those with AKI due to an abnormally high SCr.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Symptomatic patients</strong> – Signs and symptoms due to alterations of renal function including edema (due to progressive fluid accumulation), decreased or no urine output, and/or hypertension.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other abnormal laboratory tests</strong> – AKI may be first recognized because of associated electrolyte and acid-base abnormalities.</p><p></p><p class="headingAnchor" id="H783928013"><span class="h2">At-risk asymptomatic patients</span><span class="headingEndMark"> — </span>Routine testing of kidney function using SCr for at-risk neonates is the most common presentation of neonatal AKI.</p><p>We obtain SCr for all patients admitted to the neonatal intensive care unit. SCr is also obtained for any neonate with the following clinical conditions [<a href="#rid4">4,47</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Very preterm (VPT) infants (gestational age [GA] &lt;32 weeks or birth weight &lt;1500 g)</p><p class="bulletIndent1"><span class="glyph">●</span>Perinatal asphyxia (see  <a class="medical medical_review" href="/z/d/html/4975.html" rel="external">"Perinatal asphyxia in term and late preterm infants"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Critical congenital heart disease (see  <a class="medical medical_review" href="/z/d/html/5774.html" rel="external">"Identifying newborns with critical congenital heart disease"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Antenatal bilateral hydronephrosis (see  <a class="medical medical_review" href="/z/d/html/6105.html" rel="external">"Postnatal evaluation and management of hydronephrosis"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Hydrops fetalis (see  <a class="medical medical_review" href="/z/d/html/5027.html" rel="external">"Nonimmune hydrops fetalis in the neonate: Causes, presentation, and overview of neonatal management"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Septic infants treated with parenteral antibiotics</p><p class="bulletIndent1"><span class="glyph">●</span>Infants who receive total parenteral nutrition</p><p class="bulletIndent1"><span class="glyph">●</span>Following surgical procedure</p><p class="bulletIndent1"><span class="glyph">●</span>Infants who are treated with extracorporeal membrane oxygenation</p><p></p><p class="headingAnchor" id="H1803962516"><span class="h2">Symptomatic patients</span><span class="headingEndMark"> — </span>Symptoms of neonatal AKI include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Edema</strong> is common in newborns with AKI. This can result from fluid overload due to kidney dysfunction. Alternatively, other comorbid conditions can contribute to edema, such as capillary leak, heart failure, or hypoalbuminemia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Oligoanuria or anuria</strong>, defined as no urine output noted by 48 hours of age or a diminished urine output (urine volume less than 1 mL/kg per hour). However, the presence of urine does <strong>not</strong> rule out AKI, since some infants are nonoliguric [<a href="#rid48">48,49</a>]. (See <a class="local">'Time of first void and urine volume'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypertension</strong>, defined as persistent systolic and/or diastolic blood pressure (BP) that exceeds the 95<sup>th</sup> percentile for postmenstrual (sometimes referred to as postconceptional) age, may be seen in some patients with AKI  (<a class="graphic graphic_figure graphicRef50321" href="/z/d/graphic/50321.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef71407" href="/z/d/graphic/71407.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef62005" href="/z/d/graphic/62005.html" rel="external">figure 3</a>). However, assessing BP is challenging, especially in extremely preterm infants, due to technical difficulties and a great variability of BP due to effects from GA and postnatal age. (See  <a class="medical medical_review" href="/z/d/html/5001.html" rel="external">"Etiology, clinical features, and diagnosis of neonatal hypertension"</a> and  <a class="medical medical_review" href="/z/d/html/109813.html" rel="external">"Assessment and management of low blood pressure in extremely preterm infants"</a>.)</p><p></p><p class="headingAnchor" id="H635842358"><span class="h2">Presentation due to other laboratory abnormalities</span><span class="headingEndMark"> — </span>In addition to changes in SCr, AKI also may be associated with a number of electrolyte or acid-base test abnormalities. In many cases, these abnormal results are seen in conjunction with an abnormally elevated SCr. In other patients, these findings may lead to further testing, including SCr, which may be abnormal. These abnormal laboratory results include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyponatremia</strong> – Hyponatremia almost always results from an inability to excrete free water by the kidneys.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyperkalemia</strong> – Several factors may contribute to hyperkalemia in patients with AKI. These include a reduced glomerular filtration rate (GFR), decreased tubular secretion of potassium, tissue breakdown with release of intracellular potassium, and metabolic acidosis resulting in transcellular movement of potassium (each 0.1-unit reduction in arterial pH raises serum potassium by 0.3 mEq/L).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metabolic acidosis</strong> – AKI impairs the neonates' ability to regulate acid-base status due to tubular immaturity. (See <a class="local">'Tubular function'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyperphosphatemia</strong> – The kidney plays a major role in phosphate excretion. Thus, AKI, particularly if moderate to severe, can lead to hyperphosphatemia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypocalcemia</strong> – Hypocalcemia is a less common problem that can be caused by hyperphosphatemia and other factors in patients with AKI. (See  <a class="medical medical_review" href="/z/d/html/5060.html" rel="external">"Neonatal hypocalcemia"</a>.)</p><p></p><p class="headingAnchor" id="H2214539091"><span class="h2">Late-onset acute kidney injury</span><span class="headingEndMark"> — </span>Late-onset neonatal AKI occurs in infants who are older than seven days of age. In a retrospective report from the AWAKEN database, infants with late-onset AKI often had an earlier episode of AKI (28 percent) [<a href="#rid50">50</a>]. They had longer birth hospitalizations and higher mortality compared with infants without late-onset AKI and were more likely to have additional comorbidities (eg, congenital heart disease, kidney anomalies, and necrotizing enterocolitis).</p><p class="headingAnchor" id="H12"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Neonatal AKI is clinically suspected in a newborn with no urine output by 48 hours of age, diminished urine output (less than 1 mL/kg per hour), edema, or high blood pressure (BP).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic criteria</strong> – The diagnosis of neonatal AKI is usually based on an abnormally elevated serum creatinine (SCr) for gestational age (GA) and postnatal age or increasing SCr from a previous baseline. Alternatively, the diagnosis can be based on definitions that include both SCr and urine output (neonatal Kidney Disease: Improving Global Outcomes [KDIGO] definition) or cystatin C (serum cystatin C ≥2.2 mg/L or an increase in cystatin C of ≥25 percent during the neonatal period [<a href="#rid8">8</a>]). (See <a class="local">'Definition'</a> above.)</p><p></p><p class="bulletIndent1">SCr at birth is equal to the concentration in the mother (approximately 1 mg/dL [88 micromol/L]) and declines rapidly in the first one or two weeks of life in term infants and over the first one to two months in preterm infants to nadir values (SCr 0.2 to 0.4 mg/dL [18 to 35 micromol/L]). The rate of decline decreases with decreasing GA, especially in very preterm (VPT) infants (GA &lt;32 weeks)  (<a class="graphic graphic_table graphicRef111831" href="/z/d/graphic/111831.html" rel="external">table 1</a>). (See <a class="local">'Serum creatinine'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Investigational biomarkers</strong> – Research efforts are in progress to define markers of kidney injury in infants so that a diagnosis of AKI can be made before the onset of biochemical changes (SCr) and clinical symptoms [<a href="#rid51">51</a>]. Other markers include neutrophil gelatinase-associated lipocalin, urinary interleukin 18, and kidney injury molecule-1 [<a href="#rid52">52,53</a>]. However, further testing is need to establish whether any of these markers will provide beneficial clinical guidance in the diagnosis and management of AKI regardless of the age of the patient. In addition, both GA and postnatal age appear to effect the normal range of many of these markers [<a href="#rid10">10,54</a>]. As a result, it will also be imperative for studies to account for these effects before any of these markers can be used clinically. (See  <a class="medical medical_review" href="/z/d/html/85837.html" rel="external">"Investigational biomarkers and the evaluation of acute kidney injury", section on 'Overview'</a>.)</p><p></p><p class="headingAnchor" id="H3242972001"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>At birth, the distinction between acute and chronic kidney disease (CKD) may be difficult as presentations are similar. Abnormal antenatal renal ultrasound examination or the presence of dysmorphic features on physical examination is suggestive of CKD. Differentiating between the two entities is also based on the duration of kidney dysfunction. For infants with AKI, the kidney dysfunction resolves over days and weeks, whereas kidney dysfunction persists for months to years for those with CKD.</p><p>Identifying the underlying cause of kidney dysfunction is useful as it provides information on the probability of kidney function recovery. Renal ultrasound is helpful as some neonates with CKD may have identifiable congenital anomalies (eg, renal hypodysplasia) or bilateral cystic disease (eg, autosomal polycystic kidney disease). In addition, other physical findings may suggest an underlying genetic or syndromic condition associated with CKD. (See  <a class="medical medical_review" href="/z/d/html/6110.html" rel="external">"Overview of congenital anomalies of the kidney and urinary tract (CAKUT)"</a> and  <a class="medical medical_review" href="/z/d/html/111976.html" rel="external">"Neonatal acute kidney injury: Evaluation, management, and prognosis", section on 'Identifying the underlying cause'</a>.)</p><p class="headingAnchor" id="H2837025084"><span class="h1">OUTCOME</span><span class="headingEndMark"> — </span>Observational studies have reported that neonates with AKI have a higher mortality rate than infants without AKI [<a href="#rid21">21,22,24,29</a>]. In addition, longer length of birth hospitalization is observed for infants with AKI [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H1045799827"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110753.html" rel="external">"Society guideline links: Acute kidney injury in children"</a>.)</p><p class="headingAnchor" id="H1201172237"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Acute kidney injury (AKI) is an acute reduction in kidney function due to a decline in glomerular filtration rate (GFR), causing oliguria or anuria with changes in serum creatinine (SCr) and/or cystatin C. GFR is generally estimated by SCr. However, this approach has limitations in neonates because SCr varies with gestational age (GA) and postnatal age and is also insensitive to early phases of AKI. Alternatively, the diagnosis can be based on definitions that include both SCr and urine output or cystatin C. (See <a class="local">'Definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incidence</strong> – The incidence of neonatal AKI varies depending on the definition used and the characteristics of the study population. The incidence of AKI is higher in very preterm (VPT) infants (GA &lt;32 weeks) compared with older children and adults and for infants cared for in the neonatal intensive care unit. (See <a class="local">'Incidence'</a> above and <a class="local">'Definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Increased susceptibility to AKI</strong> – Newborns are more susceptible to kidney injury compared with older infants and children because of the functional and developmental immaturity of the neonatal kidney, affecting glomerular filtration and tubular function (urine-concentrating ability), hemodynamic changes that occur at delivery, and risk of hypovolemia due to large insensible water losses. Both GFR and tubular function vary based on GA and postnatal age. (See <a class="local">'Normal neonatal kidney function'</a> above and <a class="local">'Pathogenesis and etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – Causes of neonatal AKI are categorized as follows  (<a class="graphic graphic_table graphicRef63913" href="/z/d/graphic/63913.html" rel="external">table 2</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prerenal failure is caused by decreased renal perfusion due to hypovolemia or a reduced effective circulation. (See <a class="local">'Prerenal disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intrinsic renal failure is caused by renal tubular or interstitial injury, renal vascular disease, or, rarely, glomerular disorders. (See <a class="local">'Intrinsic renal disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Postrenal failure is caused by obstructive uropathy. (See <a class="local">'Postrenal disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presentation</strong> – Neonatal AKI can present due to:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An abnormal SCr value obtained by screening at-risk asymptomatic patients. (See <a class="local">'At-risk asymptomatic patients'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Symptomatic patients who present with edema, oliguria or anuria, or hypertension. (See <a class="local">'Symptomatic patients'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Electrolyte or acid-base test abnormalities that are associated with AKI, including hyponatremia, hyperkalemia, metabolic acidosis, hyperphosphatemia, and hypocalcemia. Although these abnormal results are often observed in conjunction with an abnormally elevated SCr, in some cases, these findings may lead to further testing including SCr, which may be abnormal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – AKI is clinically suspected in newborns with no urine output by 48 hours of age, a diminished urine output (less than 1 mL/kg per hour), edema, or high blood pressure (BP). The diagnosis of neonatal AKI is confirmed by an abnormally elevated SCr. (See <a class="local">'Clinical presentation'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis for AKI is the initial presentation of chronic kidney disease (CKD). At birth, the distinction between acute kidney disease and CKD is difficult as presentations are similar. Abnormal antenatal renal ultrasound examination or the presence of dysmorphic features on physical examination is suggestive of CKD. Differentiating between the two entities is based on the duration of kidney dysfunction. For infants with AKI, the kidney recovers over days and weeks, whereas kidney dysfunction persists for months to years for those with CKD. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bruel A, Rozé JC, Flamant C, et al. Critical serum creatinine values in very preterm newborns. PLoS One 2013; 8:e84892.</a></li><li><a class="nounderline abstract_t">Bruel A, Rozé JC, Quere MP, et al. Renal outcome in children born preterm with neonatal acute renal failure: IRENEO-a prospective controlled study. Pediatr Nephrol 2016; 31:2365.</a></li><li><a class="nounderline abstract_t">Jetton JG, Askenazi DJ. Update on acute kidney injury in the neonate. Curr Opin Pediatr 2012; 24:191.</a></li><li><a class="nounderline abstract_t">Selewski DT, Charlton JR, Jetton JG, et al. Neonatal Acute Kidney Injury. Pediatrics 2015; 136:e463.</a></li><li><a class="nounderline abstract_t">Nada A, Bonachea EM, Askenazi DJ. Acute kidney injury in the fetus and neonate. Semin Fetal Neonatal Med 2017; 22:90.</a></li><li><a class="nounderline abstract_t">Askenazi D, Abitbol C, Boohaker L, et al. Optimizing the AKI definition during first postnatal week using Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates (AWAKEN) cohort. Pediatr Res 2019; 85:329.</a></li><li><a class="nounderline abstract_t">Tong C, Liu Y, Wu Y, et al. Gestational and Age-Specific Cystatin C Reference Intervals for Newborns. Am J Perinatol 2022; 39:1654.</a></li><li><a class="nounderline abstract_t">Xu X, Nie S, Xu H, et al. Detecting Neonatal AKI by Serum Cystatin C. J Am Soc Nephrol 2023; 34:1253.</a></li><li><a class="nounderline abstract_t">Vieux R, Hascoet JM, Merdariu D, et al. Glomerular filtration rate reference values in very preterm infants. Pediatrics 2010; 125:e1186.</a></li><li><a class="nounderline abstract_t">Gubhaju L, Sutherland MR, Horne RS, et al. Assessment of renal functional maturation and injury in preterm neonates during the first month of life. Am J Physiol Renal Physiol 2014; 307:F149.</a></li><li><a class="nounderline abstract_t">Guignard JP, Drukker A. Why do newborn infants have a high plasma creatinine? Pediatrics 1999; 103:e49.</a></li><li><a class="nounderline abstract_t">Boer DP, de Rijke YB, Hop WC, et al. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol 2010; 25:2107.</a></li><li><a class="nounderline abstract_t">Bateman DA, Thomas W, Parravicini E, et al. Serum creatinine concentration in very-low-birth-weight infants from birth to 34-36 wk postmenstrual age. Pediatr Res 2015; 77:696.</a></li><li><a class="nounderline abstract_t">van Donge T, Allegaert K, Gotta V, et al. Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life. Pediatr Nephrol 2021; 36:649.</a></li><li><a class="nounderline abstract_t">Clark DA. Times of first void and first stool in 500 newborns. Pediatrics 1977; 60:457.</a></li><li><a class="nounderline abstract_t">FISHER DA, PYLE HR Jr, PORTER JC, et al. CONTROL OF WATER BALANCE IN THE NEWBORN. Am J Dis Child 1963; 106:137.</a></li><li><a class="nounderline abstract_t">Joppich R, Scherer B, Weber PC. Renal prostaglandins: relationship to the development of blood pressure and concentrating capacity in pre-term and full term healthy infants. Eur J Pediatr 1979; 132:253.</a></li><li><a class="nounderline abstract_t">CALCAGNO PL, RUBIN MI, WEINTRAUB DH. Studies on the renal concentrating and diluting mechanisms in the premature infant. J Clin Invest 1954; 33:91.</a></li><li><a class="nounderline abstract_t">Edelmann CM, Soriano JR, Boichis H, et al. Renal bicarbonate reabsorption and hydrogen ion excretion in normal infants. J Clin Invest 1967; 46:1309.</a></li><li><a class="nounderline abstract_t">Manz F, Kalhoff H, Remer T. Renal acid excretion in early infancy. Pediatr Nephrol 1997; 11:231.</a></li><li><a class="nounderline abstract_t">Koralkar R, Ambalavanan N, Levitan EB, et al. Acute kidney injury reduces survival in very low birth weight infants. Pediatr Res 2011; 69:354.</a></li><li><a class="nounderline abstract_t">Carmody JB, Swanson JR, Rhone ET, Charlton JR. Recognition and reporting of AKI in very low birth weight infants. Clin J Am Soc Nephrol 2014; 9:2036.</a></li><li><a class="nounderline abstract_t">Maqsood S, Fung N, Chowdhary V, et al. Outcome of extremely low birth weight infants with a history of neonatal acute kidney injury. Pediatr Nephrol 2017; 32:1035.</a></li><li><a class="nounderline abstract_t">Charlton JR, Boohaker L, Askenazi D, et al. Incidence and Risk Factors of Early Onset Neonatal AKI. Clin J Am Soc Nephrol 2019; 14:184.</a></li><li><a class="nounderline abstract_t">Starr MC, Kula A, Lieberman J, et al. The impact of increased awareness of acute kidney injury in the Neonatal Intensive Care Unit on acute kidney injury incidence and reporting: results of a retrospective cohort study. J Perinatol 2020; 40:1301.</a></li><li><a class="nounderline abstract_t">Wu Y, Wang H, Pei J, et al. Acute kidney injury in premature and low birth weight neonates: a systematic review and meta-analysis. Pediatr Nephrol 2022; 37:275.</a></li><li><a class="nounderline abstract_t">Askenazi DJ, Heagerty PJ, Schmicker RH, et al. Prevalence of acute kidney injury (AKI) in extremely low gestational age neonates (ELGAN). Pediatr Nephrol 2020; 35:1737.</a></li><li><a class="nounderline abstract_t">Hingorani S, Schmicker RH, Brophy PD, et al. Severe Acute Kidney Injury and Mortality in Extremely Low Gestational Age Neonates. Clin J Am Soc Nephrol 2021; 16:862.</a></li><li><a class="nounderline abstract_t">Elgendy MM, Othman HF, Younis M, et al. Trends and racial disparities for acute kidney injury in premature infants: the US national database. Pediatr Nephrol 2021; 36:2789.</a></li><li><a class="nounderline abstract_t">Hentschel R, Lödige B, Bulla M. Renal insufficiency in the neonatal period. Clin Nephrol 1996; 46:54.</a></li><li class="breakAll">Normal kidney development. In: Pediatric Kidney Disease, 2nd ed, Edelman CM Jr (Ed), Little, Brown and Company, Boston 1992. p.3.</li><li class="breakAll">Arant BS. Neonatal adjustments to extrauterine life. In: Pediatric Kidney Disease, 2nd ed, Edelman CM (Ed), Little, Brown and Company, Boston 1992. p.1015.</li><li><a class="nounderline abstract_t">Bueva A, Guignard JP. Renal function in preterm neonates. Pediatr Res 1994; 36:572.</a></li><li><a class="nounderline abstract_t">Tóth-Heyn P, Drukker A, Guignard JP. The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 2000; 14:227.</a></li><li class="breakAll">Awazu M, Hunley TE, Kon V. Pathophysiology of acute renal failure in the neonatal period. In: Fetal and Neonatal Physiology, 2nd ed, Polin RA, Fox WW (Eds), Saunders, Philadelphia 1998. p.1691.</li><li><a class="nounderline abstract_t">Khan RZ, Badr KF. Endotoxin and renal function: perspectives to the understanding of septic acute renal failure and toxic shock. Nephrol Dial Transplant 1999; 14:814.</a></li><li><a class="nounderline abstract_t">Badr KF. Sepsis-associated renal vasoconstriction: potential targets for future therapy. Am J Kidney Dis 1992; 20:207.</a></li><li><a class="nounderline abstract_t">Hanna MH, Askenazi DJ, Selewski DT. Drug-induced acute kidney injury in neonates. Curr Opin Pediatr 2016; 28:180.</a></li><li><a class="nounderline abstract_t">Vieux R, Fresson J, Guillemin F, Hascoet JM. Perinatal drug exposure and renal function in very preterm infants. Arch Dis Child Fetal Neonatal Ed 2011; 96:F290.</a></li><li><a class="nounderline abstract_t">Salerno SN, Liao Y, Jackson W, et al. Association between Nephrotoxic Drug Combinations and Acute Kidney Injury in the Neonatal Intensive Care Unit. J Pediatr 2021; 228:213.</a></li><li><a class="nounderline abstract_t">Goetzman BW, Stadalnik RC, Bogren HG, et al. Thrombotic complications of umbilical artery catheters: A clinical and radiographic study. Pediatrics 1975; 56:374.</a></li><li><a class="nounderline abstract_t">Boo NY, Wong NC, Zulkifli SS, Lye MS. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health 1999; 35:460.</a></li><li><a class="nounderline abstract_t">Muñoz-Arizpe R, Walsh RF, Edge W. Obstructive aortic and renal thrombosis in the newborn--spontaneous recovery. Pediatr Nephrol 1992; 6:190.</a></li><li><a class="nounderline abstract_t">Ellis D, Kaye RD, Bontempo FA. Aortic and renal artery thrombosis in a neonate: recovery with thrombolytic therapy. Pediatr Nephrol 1997; 11:641.</a></li><li><a class="nounderline abstract_t">Flynn JT. Neonatal hypertension: diagnosis and management. Pediatr Nephrol 2000; 14:332.</a></li><li><a class="nounderline abstract_t">Bökenkamp A, von Kries R, Nowak-Göttl U, et al. Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome. Eur J Pediatr 2000; 159:44.</a></li><li><a class="nounderline abstract_t">Harer MW, Selewski DT, Kashani K, et al. Improving the quality of neonatal acute kidney injury care: neonatal-specific response to the 22nd Acute Disease Quality Initiative (ADQI) conference. J Perinatol 2021; 41:185.</a></li><li><a class="nounderline abstract_t">Durkan AM, Alexander RT. Acute kidney injury post neonatal asphyxia. J Pediatr 2011; 158:e29.</a></li><li><a class="nounderline abstract_t">Timovska SN, Cekovska S, Tosheska-Trajkovska K. Acute Kidney Injury in Newborns. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2015; 36:83.</a></li><li><a class="nounderline abstract_t">Charlton JR, Boohaker L, Askenazi D, et al. Late onset neonatal acute kidney injury: results from the AWAKEN Study. Pediatr Res 2019; 85:339.</a></li><li><a class="nounderline abstract_t">Askenazi DJ, Montesanti A, Hunley H, et al. Urine biomarkers predict acute kidney injury and mortality in very low birth weight infants. J Pediatr 2011; 159:907.</a></li><li><a class="nounderline abstract_t">Bellos I, Fitrou G, Daskalakis G, et al. Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury in neonates with perinatal asphyxia: a systematic review and meta-analysis. Eur J Pediatr 2018; 177:1425.</a></li><li><a class="nounderline abstract_t">Li Y, Fu C, Zhou X, et al. Urine interleukin-18 and cystatin-C as biomarkers of acute kidney injury in critically ill neonates. Pediatr Nephrol 2012; 27:851.</a></li><li><a class="nounderline abstract_t">Saeidi B, Koralkar R, Griffin RL, et al. Impact of gestational age, sex, and postnatal age on urine biomarkers in premature neonates. Pediatr Nephrol 2015; 30:2037.</a></li></ol></div><div id="topicVersionRevision">Topic 4989 Version 45.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24386431" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Critical serum creatinine values in very preterm newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27335060" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Renal outcome in children born preterm with neonatal acute renal failure: IRENEO-a prospective controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22227783" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Update on acute kidney injury in the neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26169430" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Neonatal Acute Kidney Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28034548" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Acute kidney injury in the fetus and neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30643188" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Optimizing the AKI definition during first postnatal week using Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates (AWAKEN) cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33621984" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Gestational and Age-Specific Cystatin C Reference Intervals for Newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36977125" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Detecting Neonatal AKI by Serum Cystatin C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20368313" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Glomerular filtration rate reference values in very preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24899060" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Assessment of renal functional maturation and injury in preterm neonates during the first month of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10103341" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Why do newborn infants have a high plasma creatinine?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20505955" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Reference values for serum creatinine in children younger than 1 year of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25675426" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Serum creatinine concentration in very-low-birth-weight infants from birth to 34-36 wk postmenstrual age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32944826" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/905009" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Times of first void and first stool in 500 newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14056809" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : CONTROL OF WATER BALANCE IN THE NEWBORN.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/230048" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Renal prostaglandins: relationship to the development of blood pressure and concentrating capacity in pre-term and full term healthy infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13117970" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Studies on the renal concentrating and diluting mechanisms in the premature infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16695919" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Renal bicarbonate reabsorption and hydrogen ion excretion in normal infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9090674" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Renal acid excretion in early infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21178824" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Acute kidney injury reduces survival in very low birth weight infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25280497" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Recognition and reporting of AKI in very low birth weight infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28194575" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Outcome of extremely low birth weight infants with a history of neonatal acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31738181" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Incidence and Risk Factors of Early Onset Neonatal AKI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32681064" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The impact of increased awareness of acute kidney injury in the Neonatal Intensive Care Unit on acute kidney injury incidence and reporting: results of a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34529137" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Acute kidney injury in premature and low birth weight neonates: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32488672" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Prevalence of acute kidney injury (AKI) in extremely low gestational age neonates (ELGAN).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34117080" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Severe Acute Kidney Injury and Mortality in Extremely Low Gestational Age Neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33619659" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Trends and racial disparities for acute kidney injury in premature infants: the US national database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8832153" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Renal insufficiency in the neonatal period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8832153" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Renal insufficiency in the neonatal period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8832153" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Renal insufficiency in the neonatal period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7877873" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Renal function in preterm neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10752764" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10752764" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10328448" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Endotoxin and renal function: perspectives to the understanding of septic acute renal failure and toxic shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1519601" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Sepsis-associated renal vasoconstriction: potential targets for future therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26735892" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Drug-induced acute kidney injury in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21173011" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Perinatal drug exposure and renal function in very preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32818481" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Association between Nephrotoxic Drug Combinations and Acute Kidney Injury in the Neonatal Intensive Care Unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1161393" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Thrombotic complications of umbilical artery catheters: A clinical and radiographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10571759" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1571220" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Obstructive aortic and renal thrombosis in the newborn--spontaneous recovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9323298" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Aortic and renal artery thrombosis in a neonate: recovery with thrombolytic therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10775081" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Neonatal hypertension: diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10653328" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32892210" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Improving the quality of neonatal acute kidney injury care: neonatal-specific response to the 22nd Acute Disease Quality Initiative (ADQI) conference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21238703" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Acute kidney injury post neonatal asphyxia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27442400" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Acute Kidney Injury in Newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30546043" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Late onset neonatal acute kidney injury: results from the AWAKEN Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21784446" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Urine biomarkers predict acute kidney injury and mortality in very low birth weight infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30051145" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury in neonates with perinatal asphyxia: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22228436" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Urine interleukin-18 and cystatin-C as biomarkers of acute kidney injury in critically ill neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26001700" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Impact of gestational age, sex, and postnatal age on urine biomarkers in premature neonates.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
